CV Sciences, Inc. (CVSI) Financials

CVSI Assets vs Liabilities

DateAssetsLiabilities
March 31, 2026 6.7 million 5.2 million
Dec. 31, 2025 7.0 million 5.5 million
Sept. 30, 2025 7.0 million 5.5 million
June 30, 2025 8.0 million 6.1 million

CVSI Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 98000 148000
Dec. 31, 2025 -363000 -127000
Sept. 30, 2025 -270000 ?
June 30, 2025 238000 132000

CVSI Net Income

No data available :(

CVSI Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 309000 37000 -
Dec. 31, 2025 278000 100000 -
Sept. 30, 2025 381000 162000 -
June 30, 2025 886000 208000 469000

CVSI Shares Outstanding

No data available :(

CVSI Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 3000 18000 1.9 million -
Dec. 31, 2025 9000 18000 1.7 million -
Sept. 30, 2025 11000 24000 1.8 million 1.1 million
June 30, 2025 49000 50000 1.9 million 371000

CVSI Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 3.2 million 1.6 million
Dec. 31, 2025 3.3 million 1.6 million
Sept. 30, 2025 3.3 million 1.7 million
June 30, 2025 3.6 million 1.8 million

CVSI

Price: $0.03

52 week price:
0.02
0.10

Earnings Per Share: -0.01 USD

P/E Ratio: -6

Exchange: OQB

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 5.9 million

Links: